PDCD1 and neoplasm: Collectively, these data demonstrate the ability of CBL0137 HAI to selectively deplete MDSC populations that inhibit anti-tumor immune responses, simultaneously maintain T cell populations, and overcome anti-PD-1 resistance to improve survival in the immunologic cold 4T1 liver metastatic model.